crimeancongo
hemorrhag
fever
viru
cchfv
infect
result
sever
hemorrhag
syndrom
antivir
intervent
avail
date
certain
rna
virus
cchfv
encod
cystein
proteas
ovarian
tumor
otu
famili
antagon
interferon
ifn
product
deconjug
ubiquitin
ub
otu
cchfv
negativestrand
rna
viru
dispens
replic
viral
genom
despit
part
larg
viral
rna
polymeras
show
mutat
prevent
bind
otu
cellular
ubiquitin
requir
gener
recombin
cchfv
contain
mutat
catalyt
cystein
similarli
highaffin
bind
synthet
ubiquitin
variant
cchfv
otu
strongli
inhibit
viral
growth
inhibit
cchfv
infect
even
absenc
intact
ifn
signal
suggest
antivir
activ
due
block
otu
immunosuppress
function
instead
prolong
occup
otu
directli
target
viral
replic
interf
cchfv
rna
synthesi
togeth
data
provid
mechanist
detail
support
develop
antivir
target
viral
otu
import
crimeancongo
hemorrhag
fever
viru
import
human
pathogen
wide
global
distribut
therapeut
intervent
avail
cchfv
encod
cystein
proteas
belong
ovarian
tumor
otu
famili
involv
host
immun
suppress
demonstr
artifici
prolong
bind
otu
substrat
inhibit
viru
infect
provid
novel
insight
cchfv
otu
function
viral
replic
cycl
highlight
otu
potenti
antivir
target
western
europ
assist
migratori
bird
carri
infect
tick
long
distanc
cchf
casefat
rate
typic
rang
nosocomi
transmiss
common
patient
isol
strict
nurs
barrier
implement
nosocomi
outbreak
aid
fact
cchf
initi
manifest
nonspecif
febril
ill
therebi
increas
potenti
initi
chain
human
transmiss
although
ribavirin
use
treat
cchf
efficaci
util
clinic
set
remain
debat
licens
vaccin
altern
therapeut
option
avail
prevent
diseas
treat
patient
therefor
novel
antivir
strategi
requir
combat
outbreak
cchfv
possess
negativestrand
triseg
rna
genom
small
segment
encod
nucleoprotein
np
medium
segment
encod
glycoprotein
precursor
gpc
larg
l
segment
encod
multifunct
l
protein
contain
rnadepend
rna
polymeras
rdrp
ovarian
tumor
otu
like
cystein
proteas
domain
cchfv
otu
domain
possess
deubiquitinas
dub
deisgylas
activ
enabl
remov
ubiquitin
ub
ubiquitinlik
interferon
ifn
stimul
gene
conjug
protein
target
ub
small
protein
involv
regul
cellular
signal
includ
innat
immun
respons
innat
immun
respons
activ
immun
receptor
detect
pathogenassoci
molecular
pattern
pamp
trigger
variou
downstream
signal
pathway
result
product
interferon
activ
upregul
antivir
effector
protein
protein
ubiquitin
requir
express
type
interferon
ifn
upregul
hundr
ifnstimul
gene
critic
rapidli
restrict
viral
replic
cellular
deubiquitinas
dub
dampen
ifn
respons
remov
ub
key
protein
regul
immun
includ
rigi
mav
unsurprisingli
variou
viru
famili
encod
dub
domain
viral
dub
belong
otu
superfamili
report
positivestrand
tymovirida
arterivirida
negativestrand
nairovirida
tenuiviru
rna
virus
viral
dub
thought
facilit
viral
replic
modul
innat
immun
respons
well
reduc
ubmedi
degrad
viral
protein
proteasom
exampl
viral
dub
activ
cchfv
otu
equin
arter
viru
otu
suppress
type
ifn
signal
infect
wherea
turnip
yellow
mosaic
viru
dub
counter
ubmedi
proteasom
degrad
polymeras
studi
role
dub
encod
positivestrand
rna
virus
hinder
fact
proteas
involv
viral
polyprotein
process
requir
rdrp
matur
therefor
catalyt
inact
mutant
gener
contrast
negativestrand
rna
virus
cchfv
requir
dub
activ
rdrp
function
thu
abil
cchfv
remov
ub
conjug
absolut
requir
viral
growth
although
disrupt
shown
previous
result
enhanc
cellular
antivir
respons
addit
ub
certain
viral
dub
also
remov
conjug
target
protein
ub
conjug
lysin
k
residu
via
threestep
enzymat
cascad
compris
ubiquitinactiv
enzym
ubiquitinconjug
enzym
ubiquitin
ligas
ub
constitut
express
wherea
express
conjug
enzym
requir
ifn
stimul
ub
conjug
mediat
hundr
ligas
wherea
conjug
reli
mainli
one
ligas
isgyl
appear
larg
restrict
newli
synthes
protein
due
ribosom
associ
thu
make
isg
viral
protein
central
target
isgyl
exert
antivir
activ
prolong
antivir
signal
stat
interf
function
viral
protein
exampl
isgyl
interfer
oligomer
viral
protein
import
format
viral
particl
ribonucleoprotein
rnp
complex
therefor
viral
dub
cchfv
otu
expect
counter
innat
immun
respons
remov
ub
conjug
target
protein
make
viral
dub
attract
potenti
therapeut
target
disrupt
activ
expect
enhanc
immun
respons
upon
infect
hinder
viral
growth
gener
catalyt
inact
mutant
negativestrand
rna
viru
cchfv
investig
role
otu
infect
notabl
rescu
catalyt
inact
cchfv
requir
addit
mutat
allevi
interact
otu
cellular
ub
reveal
inactiv
inhibit
otu
domain
cchfv
block
viral
replic
likewis
engin
ubiquitin
variant
ubv
specif
cchfv
otu
also
strongli
inhibit
cchfv
growth
hinder
viral
transcript
andor
replic
despit
report
immun
suppress
function
otu
inhibit
larg
independ
otumedi
ifn
suppress
therefor
prolong
bind
otu
ub
cchfv
otuspecif
inhibitor
block
viral
infect
data
support
consid
cchfv
otu
prime
target
futur
develop
antivir
strategi
bind
negat
immunosuppress
mediat
otu
directli
inhibit
viral
transcript
andor
replic
disrupt
otu
bind
ub
permit
rescu
recombin
cchfv
contain
catalyt
inact
otu
viral
dub
thought
facilit
viral
infect
manipul
host
immun
respons
exact
mode
action
remain
elus
previous
report
effici
recoveri
dubdefici
cchfv
critic
residu
involv
ub
bind
mutat
contrast
previou
attempt
rescu
viru
contain
mutat
otu
catalyt
activ
site
fail
unexpectedli
later
attempt
gener
recombin
viru
mutat
success
sequenc
complet
viral
genom
confirm
conserv
mutat
reveal
acquisit
nonconserv
chang
posit
otu
indic
may
serv
adapt
mutat
allow
rescu
cchfv
encod
inact
otu
strikingli
critic
residu
requir
ub
bind
suggest
ub
bind
inact
otu
prevent
cchfv
rescu
examin
disrupt
ub
bind
critic
rescu
mutant
ad
mutat
disrupt
ub
bind
otu
mutant
inde
combin
mutat
result
effici
recoveri
recombin
cchfv
fig
sequenc
analysi
subsequ
passag
confirm
presenc
mutat
without
addit
chang
viral
genom
next
examin
effect
disrupt
otu
catalyt
activ
viral
growth
cell
fig
c
growth
kinet
assess
use
cchfvzsg
report
virus
measur
zsg
fluoresc
indic
viral
infect
although
minor
reduct
zsg
fluoresc
observ
otu
mutant
grew
effici
cell
unabl
mount
ifn
respons
infect
contrast
growth
sever
impair
cell
mount
robust
immun
respons
cchfv
infect
confirm
reduc
growth
kinet
mutant
virus
cell
due
cellular
immun
respons
assess
growth
kinet
virus
cell
lack
rigi
rigi
ko
knockout
fig
found
display
enhanc
growth
kinet
absenc
rigi
signal
suggest
otu
activ
absolut
requir
cchfv
infect
specif
support
viral
growth
ifncompet
cell
otu
activ
requir
cchfv
lethal
ifnar
mice
assess
role
otu
cchfv
pathogenesi
vivo
limit
fact
type
ifndefici
smallanim
model
ifnar
mice
avail
use
immunocompromis
mice
present
limit
address
immun
suppress
function
otu
model
nonetheless
provid
insight
effect
alter
otu
activ
cchfv
diseas
progress
examin
effect
otu
mutat
diseas
infect
ifnar
mice
subcutan
tissu
cultur
infect
dose
tcid
monitor
weight
health
daili
fig
mice
start
lose
weight
day
infect
infect
perform
ub
bind
disrupt
result
ill
ident
caus
wildtyp
cchfv
cchfvwt
mice
succumb
diseas
day
postinfect
dpi
clinic
differ
two
group
observ
fig
b
mice
infect
lost
weight
slightli
lower
rate
prolong
time
death
dpi
anim
surviv
infect
analysi
viral
rna
variou
tissu
time
death
euthanasia
demonstr
similar
viral
load
group
except
survivor
cchfv
rna
level
markedli
lower
fig
togeth
data
demonstr
otu
catalyt
activ
requir
pathogenesi
mice
absenc
type
ifn
signal
although
mutat
catalyt
site
result
mild
attenu
vivo
comparison
activ
otu
wt
block
otu
activ
otu
positivestrand
rna
virus
involv
proteolyt
process
viral
protein
requir
polymeras
matur
therefor
indispens
replic
contrast
otu
negativestrand
rna
virus
like
cchfv
essenti
rna
polymeras
activ
howev
data
suggest
inactiv
catalyt
site
cchfv
otu
also
interfer
viral
transcript
andor
replic
due
interact
cellular
ub
fig
result
inabl
cleav
substrat
may
display
prolong
bind
ubiquitin
substrat
potenti
affect
l
protein
stabil
function
ultim
prevent
viral
growth
ration
block
otu
catalyt
site
cchfvwt
use
inhibitor
could
imped
viral
infect
similar
fashion
synthet
ub
variant
ubv
bind
cchfv
otu
high
level
affin
specif
vitro
recent
describ
resembl
cellular
ub
consensu
lrlrgg
motif
requir
cleavag
conjug
ub
protein
mutat
fig
prevent
cleavag
otu
thu
resembl
inhibitori
bind
cellular
ub
furthermor
contain
extend
ctermin
tail
form
addit
contact
otu
result
enhanc
affin
use
set
investig
potenti
antivir
effect
block
cchfv
otu
activ
control
wildtypelik
ub
variant
use
ctermin
digli
motif
mutat
alanin
ubvaa
mutat
motif
ub
variant
prevent
conjug
cellular
viral
protein
therefor
result
lower
likelihood
interfer
normal
ub
conjug
confirm
interact
otuwt
use
timeresolv
fluoresc
reson
energi
transfer
trfret
cell
transfect
plasmid
express
hemagglutinintag
ubiquitin
haub
plasmid
express
subsequ
label
donor
acceptor
fluorophor
plasmid
express
green
fluoresc
protein
gfp
use
control
close
proxim
protein
proteinprotein
interact
result
increas
intens
fluoresc
signal
coexpress
either
otuwt
result
increas
trfret
signal
wherea
coexpress
either
otu
gfp
fig
contrast
coexpress
haub
result
increas
trfret
signal
wherea
coexpress
otuwt
support
concept
cellular
ub
haub
bind
wherea
synthet
also
interact
otuwt
reaffirm
interact
otuwt
use
coimmunoprecipit
cell
transfect
plasmid
encod
haotuwt
flagubvaa
control
pulldown
haotuwt
result
detect
flagubvaa
fig
examin
effect
cchfv
otu
deubiquitinas
deisgylas
activ
visual
cellular
ubiquitin
isgyl
protein
cell
transfect
plasmid
express
haub
dub
assay
combin
enzym
requir
conjug
deisgyl
assay
analysi
cellular
level
ub
demonstr
effici
block
otumedi
remov
ub
protein
target
wherea
ubvaa
effect
otu
activ
fig
addit
block
otu
dub
activ
enhanc
ubiquitin
l
protein
see
fig
supplement
materi
sinc
cchfv
otu
deubiquitinas
activ
suffici
block
rigimedi
type
ifn
signal
investig
could
affect
otumedi
immun
suppress
report
assay
fig
rigimedi
induct
beta
ifn
gene
express
measur
cell
transfect
plasmid
encod
constitut
activ
rigi
card
domain
luciferas
control
promot
effici
block
cchfv
otu
support
idea
block
otu
activ
otu
immunesuppress
activ
prevent
coexpress
taken
togeth
experi
demonstr
abil
block
proteolyt
activ
cchfv
otu
restor
cellular
rigi
signal
select
inhibit
cchfv
otu
wide
geograph
distribut
cchfv
reflect
consider
genet
divers
assess
abl
inhibit
otu
activ
diverg
cchfv
strain
nairoviru
speci
perform
vitro
otu
activ
assay
increas
concentr
incub
purifi
otu
fluorogen
ub
substrat
ubiquitin
ubamc
inhibit
vitro
otu
activ
test
cchfv
strain
hoti
oman
similar
level
effici
ic
valu
rang
nm
fig
see
also
tabl
supplement
materi
contrast
otu
nairoviru
speci
show
rel
poor
inhibit
demonstr
specif
cchfv
strain
test
distantli
relat
virus
fig
see
also
tabl
inhibit
cchfv
replic
assess
inhibit
otu
activ
affect
cchfv
replic
gener
cell
line
stabli
express
control
ubvaa
analyz
growth
kinet
cchfvzsg
report
viru
cell
measur
viral
titer
zsg
fluoresc
indic
viral
replic
protein
synthesi
fig
c
strikingli
robustli
reduc
zsg
level
test
time
point
wherea
ubvaa
control
affect
zsg
fluoresc
fig
addit
cchfvinfect
cell
produc
low
undetect
level
viral
progeni
wherea
cell
produc
titer
similar
measur
control
cell
unmodifi
cell
fig
b
infecti
titer
cchfv
lack
zsg
report
cchfvwt
close
match
curv
determin
basi
zsg
fluoresc
support
quantif
cchfvderiv
zsg
fluoresc
accur
estim
viral
growth
fig
c
final
ensur
inhibit
cchfv
growth
specif
caus
broad
antivir
effect
use
lassa
report
viru
lasv
express
zsg
lasvzsg
control
fig
lasvzsg
growth
kinet
unaffect
confirm
specif
potent
inhibit
cchfv
inhibit
cchfv
replic
independ
innat
immun
respons
sinc
cchfv
requir
otu
activ
autoproteolyt
process
viral
protein
polymeras
activ
expect
would
reduc
cchfv
infect
interf
otumedi
immun
suppress
would
result
enhanc
cellular
immun
respons
cell
display
robust
ifn
respons
upon
cchfv
infect
previou
studi
demonstr
rigi
signal
play
pivot
role
antivir
cellular
respons
cchfv
infect
investig
inhibit
cchfv
infect
depend
enhanc
cellular
immun
respons
assess
antivir
activ
rigi
knockout
cell
line
rigi
ko
use
rigi
ko
cell
basi
gener
addit
cell
line
stabli
express
ubvaa
interestingli
robust
inhibit
cchfv
note
even
absenc
rigimedi
antivir
respons
fig
confirm
inhibit
cchfv
infect
independ
rigi
otu
residu
requir
ub
bind
critic
antivir
activ
data
support
model
bind
cellular
ub
inact
otu
block
recoveri
infecti
cchfv
bind
otuwt
mimic
inhibit
fig
c
specif
otu
mutat
describ
select
disrupt
otu
interact
ub
sinc
interact
otu
manner
similar
seen
cellular
ub
expect
mutat
would
prevent
bind
otu
therefor
would
reliev
inhibit
cchfv
infect
recombin
virus
contain
otu
mutat
gener
use
infect
cell
express
predict
mutant
virus
defici
ub
bind
inhibit
wherea
retain
signific
ub
bind
inhibit
similarli
wt
viru
fig
f
h
confirm
specif
bind
mutant
otu
perform
coimmunoprecipit
experi
fig
thu
bind
otu
domain
requir
inhibit
cchfv
infect
disrupt
viral
rna
transcript
andor
replic
pinpoint
step
cchfv
replic
cycl
affect
use
minigenom
assay
viruslik
particl
vlp
assay
system
advantag
separ
variou
step
viral
replic
cycl
potenti
affect
provid
insight
mechan
action
vlp
assay
allow
us
address
earli
step
replic
cycl
entri
uncoat
primari
transcript
encapsid
minigenom
interestingli
vlp
ad
cell
mild
reduct
vlp
report
activ
compar
ubvaa
control
detect
fig
order
confirm
vlp
result
genuin
viru
use
cchfv
report
express
nanoluciferas
cchfvnluc
fig
overal
inhibit
luciferas
express
earli
infect
suggest
like
affect
viral
genom
amplif
without
interf
entri
primari
transcript
next
use
minigenom
assay
examin
whether
affect
lrdrp
activ
fig
sever
hamper
cchfv
minigenom
report
activ
suggest
affect
transcript
replic
viral
rna
confirm
interfer
product
nascent
viral
rna
simpli
translat
thereof
assess
minigenom
rna
level
presenc
fig
inde
less
viral
rna
produc
presenc
wherea
ubvaa
affect
minigenom
rna
level
experi
demonstr
affect
viral
transcript
andor
replic
exact
mechan
requir
gener
nascent
cchfv
rna
elucid
howev
cchfv
like
replic
genom
materi
way
similar
relat
bunyavirus
process
entail
np
bind
genom
rna
form
ribonucleoprotein
rnp
complex
turn
interact
l
protein
result
transcript
replic
region
requir
lnp
interact
identifi
n
c
termini
cchfv
l
protein
investig
possibl
interfer
cchfv
transcript
andor
replic
disrupt
format
rnp
complex
assess
interact
l
np
presenc
cell
transfect
plasmid
express
cchfv
np
flagubvaa
lysat
immunoprecipit
use
analyz
western
blot
assay
demonstr
less
np
associ
presenc
fig
support
model
interfer
format
cchfv
replic
complex
variou
highli
pathogen
rna
virus
includ
cchfv
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
encod
dub
domain
contain
deubiquitinas
deisgylas
activ
viral
dub
like
contribut
viral
pathogenesi
suppress
innat
immun
respons
addit
dub
positivestrand
rna
virus
essenti
viral
polyprotein
process
requir
polymeras
matur
despit
part
rna
polymeras
dub
encod
negativestrand
rna
virus
famili
nairovirida
term
otu
dispens
polymeras
activ
instead
suppress
host
immun
respons
appear
main
function
nairoviru
otu
mutat
otu
employ
synthet
ub
variant
character
effect
disrupt
otu
activ
cchfv
infect
unexpectedli
discov
sole
mutat
otu
catalyt
site
abolish
viral
propag
prolong
bind
substrat
ub
interfer
transcript
andor
genom
amplif
similarli
noncleav
synthet
ub
variant
inhibit
propag
wildtyp
cchfv
fig
cchfv
propag
absenc
otu
catalyt
activ
restor
inclus
addit
mutat
prevent
ub
bind
suggest
bind
inact
otu
cellular
ub
inhibit
viral
growth
importantli
appear
mediat
simpl
differ
affin
level
otuwt
isotherm
titrat
calorimetri
result
show
chang
favor
bind
monoub
otuwt
see
tabl
supplement
materi
howev
cellular
ub
often
found
polymer
chain
cchfv
otu
demonstr
cleav
ub
chain
although
structur
studi
reveal
interact
cchfv
otu
singl
ub
within
wellcharacter
bind
site
biochem
evid
suggest
presenc
secondari
bind
site
nairoviru
otu
facilit
interact
ub
chain
otuwt
cleav
ub
chain
convert
singl
highaffin
interact
two
loweraffin
one
facilit
substrat
releas
hand
unabl
cleav
ub
chain
result
prolong
associ
ub
subsequ
block
viru
replic
similarli
block
viral
transcript
andor
replic
prolong
associ
otuwt
due
absenc
consensu
cleavag
motif
combin
presenc
extra
interact
residu
increas
bind
affin
conclus
prolong
ubotu
associ
due
absenc
either
otu
catalyt
activ
ub
consensu
cleavag
motif
appear
suffici
inhibit
cchfv
transcript
andor
replic
previous
demonstr
intact
otu
domain
requir
cchfv
rdrp
activ
gener
recombin
cchfv
contain
catalyt
inact
otu
confirm
otu
proteas
activ
consid
accessori
viru
replic
fact
easili
propag
ifndefici
cell
pathogen
ifnar
mice
howev
weight
loss
mortal
slightli
delay
compar
mice
infect
cchfvwt
two
anim
surviv
infect
fig
antivir
respons
independ
type
ifn
includ
upregul
certain
isg
describ
immunocompromis
anim
may
respons
observ
vivo
attenu
unexpectedli
found
occupi
otu
result
strong
inhibit
cchfv
transcript
andor
replic
notabl
find
cchfv
requir
autoproteolyt
process
viral
rna
polymeras
inhibit
dub
therefor
expect
interfer
abil
suppress
host
immun
mechanist
inhibit
cchfv
character
strong
reduct
cchfv
minigenom
report
activ
fig
wherea
earli
infect
event
minim
affect
fig
b
data
support
model
prolong
bind
otu
ub
v
interfer
format
new
rnp
complex
thu
affect
viral
transcript
andor
genom
amplif
format
cchfv
rnp
complex
involv
interact
viral
rna
np
l
protein
presenc
less
np
associ
l
protein
transfect
cell
suggest
possibl
defect
rnp
complex
format
fig
np
bind
occur
two
distinct
site
locat
n
c
termini
l
might
differ
affect
bind
otu
possibl
explain
residu
interact
np
l
detect
presenc
cchfv
l
protein
harbor
rna
polymeras
otu
unusu
larg
protein
kda
tridimension
arrang
otu
domain
rel
rna
polymeras
unknown
therefor
consequ
prolong
otu
bind
respect
polymeras
conform
activ
present
unpredict
conceiv
bind
otu
domain
might
simpli
lock
polymeras
inact
state
prevent
rna
synthesi
structur
data
combin
vitro
assay
necessari
elucid
precis
mechan
complex
interfer
transcript
replic
found
otu
bind
ub
respons
block
viru
growth
absenc
proteas
activ
similarli
specif
inhibit
cchfvotu
directli
interf
viral
propag
demonstr
prolong
associ
otu
cellular
ub
inhibitor
suffici
sever
impair
cchfv
growth
inhibit
vitro
otu
activ
genet
divers
cchfv
strain
littl
effect
otu
activ
nairoviru
speci
fig
g
nairovir
otu
domain
display
high
degre
sequenc
divers
potenti
affect
bind
affin
exampl
tyr
improv
hydrophob
pack
otu
residu
thr
val
val
thr
conserv
across
four
test
cchfv
otu
wherea
test
nairoviru
speci
predominantli
encod
glutam
acid
posit
addit
otu
amino
acid
appear
interact
extens
tail
region
display
high
level
sequenc
variat
nairoviru
speci
inde
four
test
cchfv
strain
contain
gln
wherea
nairoviru
speci
drug
develop
cchfv
public
health
prioriti
specif
therapeut
demonstr
efficaci
current
avail
demonstr
stabl
occup
otu
enhanc
host
antivir
respons
also
decreas
viral
growth
interf
format
rnp
complex
illustr
target
viral
otu
negativestrand
rna
virus
viabl
antivir
strategi
therefor
data
provid
import
framework
research
develop
smallmolecul
inhibitor
target
otu
recapitul
interact
candid
drug
would
need
inhibit
otu
catalyt
activ
maintain
enhanc
high
level
affin
otu
ub
chain
take
result
togeth
studi
demonstr
stabl
occup
otu
block
viral
transcriptionrepl
inhibit
otu
suppress
ifn
antagonist
function
therebi
disrupt
critic
viral
process
cchfv
pathogenesi
report
demonstr
antivir
potenti
target
viral
otu
serv
import
proof
concept
ration
design
otuspecif
antivir
block
viru
infect
multipl
level
biosafeti
ethic
statement
anim
procedur
approv
cdc
institut
anim
care
use
committe
conduct
accord
guid
care
use
laboratori
anim
aaalacaccredit
facil
procedur
conduct
lasv
cchfv
cchfvinfect
anim
perform
biosafeti
level
facil
center
diseas
control
prevent
atlanta
ga
usa
experi
involv
cdna
encod
viral
sequenc
perform
accord
approv
institut
biosafeti
committe
protocol
cell
rigi
ko
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
mm
sodium
pyruv
nonessenti
amino
acid
uml
antibiot
cell
gift
k
k
conzelmann
munich
germani
rigi
knockout
cell
obtain
invivogen
virus
recombin
cchfv
gener
previous
describ
genbank
access
briefli
cell
transfect
plasmid
encod
fulllength
l
genom
segment
control
promot
helper
plasmid
express
cchfv
np
codonoptim
l
protein
polymeras
virus
mutat
otu
gener
ad
point
mutat
plasmid
use
sitedirect
mutagenesi
viru
rescu
report
cchfv
describ
previous
contain
code
sequenc
fuse
np
separ
sequenc
nanolucexpress
cchfv
gener
use
clone
strategi
recombin
lasv
report
lasvzsg
describ
previous
recombin
virus
verifi
deepsequenc
technolog
use
miniseq
system
illumina
viru
infect
measur
titrat
cell
either
use
zsg
readout
use
immunofluoresc
anticchfv
polyclon
antibodi
hyperimmun
mous
ascet
fluid
gener
inhous
median
tissu
cultur
infect
dose
tcid
determin
anim
experi
femal
mmjax
mice
mmrrc
hous
climatecontrol
laboratori
night
cycl
anim
given
steril
water
food
ad
libitum
group
hous
autoclav
corn
cob
bed
bedocob
anderson
lab
bed
thick
isolatorcag
system
thoren
cage
inc
hazleton
pa
usa
hepafilt
inlet
exhaust
air
suppli
cage
environ
enrich
shred
paper
cotton
nestlet
assess
variou
cchfv
mutant
virus
anim
week
age
mice
per
group
inocul
subcutan
interscapular
region
tcid
cchfv
dilut
dmem
mice
human
euthan
indic
time
point
clinic
ill
score
base
piloerect
decreas
activ
neurolog
sign
eg
ataxia
paresisparalysi
dehydr
dyspnea
andor
weight
loss
baselin
dpi
indic
anim
distress
termin
stage
diseas
differ
weight
chang
baselin
accord
day
postinfect
surviv
statist
analyz
multipl
test
signific
determin
use
holmsidak
method
log
rank
mantelcox
test
respect
graphpad
prism
quantit
rtpcr
nucleic
acid
extract
blood
homogen
tissu
use
magmax
technolog
thermo
fisher
scientif
abi
magmax
extract
platform
rna
quantifi
use
onestep
realtim
pcr
rtpcr
target
nucleoprotein
gene
sequenc
primer
probe
sequenc
avail
request
data
normal
rna
level
viral
segment
copi
number
determin
use
standard
prepar
segment
rna
transcrib
vitro
trfret
unmodifi
ubvaa
control
describ
previous
gene
synthes
insert
vector
variant
contain
ntermin
tag
flag
tag
otu
domain
amino
acid
synthes
clone
contain
ctermin
ha
tag
genscript
proteinprotein
interact
examin
use
timeresolv
fluoresc
energi
transfer
trfret
cell
seed
dish
transfect
wt
pcdnahaub
pcdnaegfp
two
day
posttransfect
cell
harvest
triton
lysi
buffer
triton
mm
trishcl
mm
mgcl
clarifi
centrifug
min
rpm
lysat
incub
room
temperatur
trfret
donor
acceptor
pair
examin
interact
haub
lysat
incub
donor
acceptor
examin
interact
lysat
incub
donor
perkin
elmer
antiflag
acceptor
cisbio
fluoresc
transfer
determin
use
synergi
plate
reader
biotek
calcul
ratio
donor
excit
acceptor
excit
coimmunoprecipit
cell
seed
dish
transfect
indic
plasmid
necessari
total
amount
plasmid
dna
supplement
pcdnaegfp
transfect
perform
use
miru
follow
manufactur
instruct
day
cell
harvest
lyse
triton
lysi
buffer
triton
mm
trishcl
mm
mgcl
clarifi
supernat
incub
antiha
antiflag
magnet
bead
h
wash
highsalt
triton
lysi
buffer
triton
mm
trishcl
mm
mgcl
mm
nacl
protein
elut
bead
ad
laemmli
sampl
buffer
heat
sampl
min
protein
subsequ
separ
bistri
sdspage
gel
transfer
nitrocellulos
membran
use
transblot
system
biorad
otu
blockag
ubiquitin
inhibit
cchfv
infect
western
blot
antibodi
cell
lysat
harvest
laemmli
sampl
buffer
heat
min
protein
subsequ
separ
bistri
trisacet
sdspage
gel
transfer
nitrocellulos
membran
use
transblot
system
biorad
follow
antibodi
use
studi
cchfv
antinp
ibt
bioservic
antiha
antiflag
thermo
fisher
tubulin
sigma
use
load
control
marker
primari
antibodi
detect
supersign
west
dura
fast
western
blot
kit
thermo
fisher
protein
band
visual
use
chemidoc
mp
system
biorad
otu
activ
transfect
cell
otu
activ
determin
cotransfect
cell
pcdnahaub
dub
assay
follow
plasmid
encod
protein
requir
isgyl
j
huibregts
univers
texa
austin
genscript
assess
effect
ubv
otu
activ
pcdnaegfp
pcdnaflagaa
cotransfect
plasmid
express
cchfvotu
plasmid
transfect
perform
use
transit
transfect
reagent
miru
ub
conjug
level
determin
h
posttransfect
western
blot
rigi
luciferas
report
assay
rigimedi
respons
assess
cotransfect
cell
plasmid
encod
rigi
card
best
rocki
mountain
laboratori
report
plasmid
encod
firefli
luciferas
control
promot
fujita
kyoto
univers
plasmid
constitut
express
renilla
luciferas
use
transfect
normal
plasmid
encod
cchfv
otu
ubiquitin
variant
cotransfect
assess
effect
rigimedi
respons
firefli
activ
renilla
luciferas
activ
quantifi
use
dualglo
luciferas
assay
system
promega
combin
synergi
plate
reader
biotek
inhibit
vitro
otu
activ
nairoviru
otu
express
purifi
previous
describ
vector
transform
escherichia
coli
cell
grown
optic
densiti
od
express
induc
mm
iptg
overnight
cell
pellet
centrifug
g
min
store
pellet
resuspend
buffer
mm
nacl
mm
sodium
acet
mm
hepe
ph
supplement
mg
lysozym
min
cell
lyse
sonic
power
duti
cycl
min
lysat
centrifug
g
supernat
pool
filter
filter
clarifi
lysat
pour
nickelnitrilotriacet
acid
ninta
column
gold
biotechnolog
olivett
mo
equilibr
buffer
column
wash
column
volum
buffer
supplement
mm
imidazol
follow
protein
elut
buffer
supplement
mm
imidazol
eluat
subsequ
filter
filter
purifi
size
exclus
use
superdex
column
ge
healthcar
equilibr
buffer
b
mm
nacl
mm
hepe
ph
mm
dithiothreitol
dtt
sampl
fraction
contain
absorb
peak
analyz
sdspage
fraction
contain
pure
pool
concentr
subsequ
flashfrozen
glycerol
store
reaction
determin
inhibitori
effect
differ
otu
perform
use
clariostar
plate
reader
bmg
labtech
reaction
run
total
volum
l
mixtur
contain
mm
nacl
mm
hepe
ph
mm
dtt
bovin
serum
albumin
bsa
nm
otu
ubiquitin
ubamc
boston
biochem
otu
test
triplic
concentr
rang
nm
otu
incub
min
reaction
initi
ad
ubamc
monitor
increas
fluoresc
reaction
rate
determin
use
linear
portion
curv
percent
inhibit
calcul
ic
relat
error
determin
use
sigmaplot
enzym
kinet
modul
util
michaelismenten
kinet
systat
softwar
inc
ubvexpress
stabl
cell
line
cell
stabli
express
ubvaa
gener
use
lentivirus
first
gateway
technolog
use
transfer
ubv
gene
pscrpsi
lentivir
vector
contain
red
fluoresc
protein
rfp
puromycin
resist
gene
c
rice
rockefel
univers
ny
lentiviru
gener
transfect
lentix
cell
clontech
packag
vector
express
vesicular
stomat
viru
protein
g
vsvg
addgen
pscrpsyflagubv
use
roch
day
supernat
collect
centrifug
min
g
filter
filter
hepe
polybren
ad
reach
final
concentr
mm
gml
respect
lentivirus
store
use
stabl
ko
cell
line
gener
puromycin
select
transduct
minigenom
assay
cchfv
minigenom
assay
use
describ
previous
briefli
cchfv
minigenom
encod
nanoluc
gene
flank
cchfv
noncod
region
control
polymeras
analyz
rdrp
activ
cell
transfect
plasmid
encod
minigenom
cchfv
np
codonoptim
cchfv
l
polymeras
firefli
luciferas
transfect
control
promega
use
miru
h
luciferas
activ
assess
use
nanoglo
luciferas
assay
system
promega
detect
nanoluc
signal
luciferas
assay
system
promega
detect
firefli
luciferas
signal
luminesc
read
carri
use
synergi
plate
reader
biotek
cchfv
minigenom
rna
level
analyz
extract
rna
transfect
cell
use
magmax
rna
isol
reagent
thermo
fisher
scientif
cchfv
minigenom
rna
quantifi
use
quantit
realtim
pcr
qrtpcr
assay
target
nanoluc
integr
dna
technolog
primer
probe
sequenc
avail
request
normal
housekeep
gene
thermo
fisher
scientif
viruslik
particl
vlp
assay
gener
cchf
vlp
describ
previous
briefli
cell
transfect
plasmid
combin
use
minigenom
assay
addit
plasmid
express
codonoptim
gpc
vlpcontain
supernat
harvest
day
posttransfect
transfer
cell
stabli
express
ubvaa
nanoluc
activ
determin
next
day
measur
vlp
activ
supplement
materi
articl
may
found
http
fig
tif
file
mb
